Tags Posts tagged with "Daniel Dunaief"

Daniel Dunaief

Above, from left, Kenneth Kaushansky, Dean of the Renaissance School of Medicine; Anissa Abi-Dargham; Henry Tannous; Ute Moll; and Michael Bernstein, Interim President of SBU.

By Daniel Dunaief

A heart and lung doctor, a researcher who works on imaging for schizophrenia and a scientist working with a mutation that affects cancer last month received endowed inaugural chair positions at Stony Brook University.

Ute Moll is the Renaissance Endowed Professor in Cancer Biology, Anissa Abi-Dargham is the Lourie Endowed Chair in Psychiatry and Henry Tannous is the General Ting Feng Cheng Endowed Chair in Cardiothoracic Surgery.

In addition to adding the prestigious titles and winning support from local benefactors and philanthropists, the three researchers will each receive annual financial support from their positions that will sustain their research and education efforts. TBR News Media is highlighting the research from each of these standout scientists.

Ute Moll

Ute Moll

A native of Germany, Ute Moll, who is studying the six most common mutated forms of the highly researched p53 gene, is grateful for the donors, the funds and the recognition. “It’s pretty prestigious to have an endowed chair or professorship attached to your name or title,” she said 

Moll described the p53 mutations as the “most common mutation in cancer.” She has been working with a mouse model. The p53 R248 hotspot is the single most common variant in all p53 altered tumor types, which occurs in about 66,000 newly diagnosed cancer patients in the United States each year.

If these mice also have a gene called Myc, they get either liver or colon cancer. By receiving an estrogen derivative drug called Tamoxifen, which is used in breast cancer, the active, mutated version of the p53 gene is turned off when another gene called Cre recombinase is activated. By removing the p53 gene, the mice live two to three times longer than they would have.

In a typical mouse, cancer can cause over 100 tumor nodules, leaving almost no normal liver. When Moll and her colleagues turned off the mutant gene, the size of the cancer is much more limited, with only a few remaining nodules.

One particular mouse lived for more than two months, eventually dying of an unrelated lymphoma. The liver, however, which had an infection across the entire organ, didn’t show a single trace of a tumor. It was completely normal, despite the ubiquitous tumor nodules before treatment.

Thus far, targeting this mutated p53 is a concept Moll and her colleagues have developed in pre-clinical mouse models of lymphoma, colon and liver cancer, but it doesn’t yet have a clinical application. 

Liver cancer used to be relatively rare in the population, driven largely by infection from hepatitis B and hepatitis C, as well as through alcoholism. Amid an epidemic of obesity, people are developing a chronically inflammatory liver condition, which increases the incidence of liver cancer.

Anissa Abi-Dargham

Anissa Abi-Dargham

A specialist in Positron Emission Tomography (or PET) imaging for schizophrenia, Anissa Abi-Dargham is pleased with the opportunity to deploy the funds for her work at her discretion.

“The beauty of these funds is that they are totally flexible,” she explained, adding that she plans to use the funds to pursue new research ideas that might not otherwise get funding until she can use data to prove a concept or principal. 

“This is really a great honor because it means that the institution believes in you and wants to invest and retain you,” she said.

In her work, Abi-Dargham has been using imaging to see what is causing dopamine dis-regulation, either with too much or too little of the neurotransmitter. 

She is looking at two systems that may explain the imbalance: the cholinergic system and the kappa opioid system.

Abi-Dargham had been at Columbia University for 20 years before joining Stony Brook over three years ago. She appreciates the school investing in a state-of-the-art imaging center. “The people in charge of this imaging center are very much investing in promoting imaging for neuroscience and psychiatry,” she said.

Based on her findings in schizophrenia, other investigators in the United Kingdom have documented dopamine levels before schizophrenia symptoms begin.

She hopes her research discovers biomarkers that can be used to predict who is going to convert to having schizophrenia.

Patients do better when the onset of symptoms is later in their lives because their more mature brain has fostered better organized life, skill sets, and relationships.

She is also testing whether other markers, such as a neuromelanin, which is a metabolite of dopamine and binds iron-like materials, will show up on a Magnetic Resonance Imaging scan before the disease.

Henry Tannous

Henry Tannous

Henry Tannous joined Stony Brook University in 2016 and is excited to be a part of the current team and to help shape the future of clinical practice and research.

Tannous called the endowed chair position an “absolute honor.” It will not only allow him to continue with his current work, but it’s also going to enable him to expand his research. He will also use some of the funds to provide continuing education for his staff.

The financial support will allow him to hire research assistants and access national databases. Tannous and his research team of cardiothoracic and lung scientists use registries from the New York State Department of Health registry and the Society of Thoracic Surgeons, each of which provides the data for a price.

With his lung work, Tannous focuses on state 1 lung cancer. Traditionally, he said, people have received a diagnosis late in the development of the disease. Over the past few years, doctors have diagnosed patients at an earlier point.

Earlier diagnoses became more prevalent after Medicare approved lung cancer screening in 2015, which picked up more cases while patients were still in the earlier stages, when the cancer might otherwise be asymptomatic.

“We would like to know more about how the disease affects [patients] and their quality of life,” Tannous said. His lab has a collaboration with Mount Sinai Hospital to learn more about the effect of the disease on the lives of the patients.

With his heart research, he’s focusing on aortic disease and is testing the limits of the Trans Catheter Aortic Valve Replacement.

Photos courtesy of SBU

By Daniel Dunaief

Two researchers from Brookhaven National Laboratory were stuck on a ship trapped in ice near the North Pole — and they couldn’t have been happier.

In fact, one of them, Matt Boyer, an Atmospheric Scientist at BNL, is returning to the German ship Polarstern for six of the next seven months. The Polarstern is part of a 20-nation effort that will gather information about the Arctic to understand climate change. The scientific collaboration, called MOSAiC (Multidisciplinary Drifting Observatory for the Study of Arctic Climate), started in September and will involve collecting data for a full year.

The scientists are measuring aerosols, cloud particles, and other data through conditions that are among the most challenging on the planet. Researchers aboard the Polarstern regularly endure cold temperatures, fierce winds, minimal to no sunlight and the threat of polar bears unafraid of humans.

Janek Uin, an Associate Atmospheric Scientist at BNL, is working with instruments that measure properties of atmospheric aerosol particles such as their size, the concentration of particles per unit volume of air, how the particles are affected by water vapor and how much light the particles scatter, which affects the sunlight that reaches the Earth’s surface.

Arthur Sedlacek, an atmospheric chemist with the Environmental & Climate Sciences Department at BNL, is one of a host of scientists collecting data from the Polarstern. Indeed, Sedlacek traveled to Tromsø Norway when the ship departed, where he prepared to measure the accumulation of black carbon in the Arctic. 

Caused by burning fossil fuels, emissions from distant wildfires, among other things, black carbon can cause polar ice to melt. When there is sun, the black carbon prevents the reflection of the light, which further darkens the white surface, either through exposure of the underlying ground or previously deposited black carbon.

Sedlacek, who did not travel aboard the Polarstern, said scientists around the world are “itching to see the data” from this ambitious mission. The data collection is “so unique and so important that it will not only help us better understand the current (pristine) state of the cryosphere, but it will also [allow scientists] to better understand (and quantify) how the Arctic is responding to climate change.”

Uin, who is an instrument mentor for about 30 instruments worldwide, recalled how he went out for a fire drill. Following his designated path and waiting for the signal to return, Uin decided to snap some pictures of a frozen and uneven landscape that appeared blue during much of the day, when the faint rays of the sun barely made it over the horizon. Unable to maneuver the camera to his satisfaction, Uin took off his gloves. His exposed fingers became numb in the wind. After he put his gloves back on, it took about 10 minutes for the feeling to return to his hands.

Boyer, meanwhile, who spent more of his time working outside than Uin, helped set up the meteorological site about 1 kilometer away from the ship and is monitoring the size and concentration of organic and inorganic aerosol particles.

The size and concentration of the particles determines how they behave in atmospheric processes, Boyer explained. The size of the particle influences its light scattering ability, how long it stays in the atmosphere, the human health impact and its ability to form clouds, among other properties.

The process of working near the North Pole requires a high level of patience. A task that might take two hours in a lab, for example, might require as long as four days to complete in Arctic conditions.

Boyer described how the moisture from his own breath sometimes froze in his face. “I prefer not to wear goggles” because they fog up, he explained. When he exhaled, the water vapor in his breath caused his eyelids to freeze shut. “You have to constantly close your eyes and pull the ice off your eyelids.”

Boyer had to hold onto a piece of metal when it was well below 0 degrees Fahrenheit and windy. Placing the bolts, nuts and screws into a hole with a glove on is “almost impossible,” Boyer said, although once those items are in place, holding a wrench with gloves on is manageable

Each time people work outside, polar bear guards constantly watch the horizon to make sure the carnivorous creatures don’t approach scientists. While the ship is not a cruise vessel, it offers pleasant amenities, including a small pool, a sauna, an exercise room and nourishment Uin and Boyer, who were roommates aboard the Polarstern, appreciated.

“The food was excellent,” Uin said. “Working long hours in extreme conditions in close quarters, the food has to be good. If it’s bad, morale plummets.” The scientist has been on three ice breakers and the food has always been high quality. 

Uin appreciated the opportunity to take the journey and to conduct the scientific research. “I am reminded how lucky I am that people trust me to do this,” he said.

Uin enjoys the opportunity to look at the ice, which appears blue because of the low light. “People think it’s all white,” he said. “There’s a constant twilight and an all-encompassing blue.” He is excited to look at the information the instruments collect and is “certain that the data will help to bring new insights into the very complex processes governing Earth’s climate and help better predict future trends.”

Boyer, who plans to leave BNL this month to pursue his PhD at the University of Helsinki, said he appreciated the opportunity to be a part of a multi-national team. “I’m one of the luckier people on the planet,” Boyer said. “Not many people will see the Arctic and the Antarctic and I’ve seen both,” adding that there is a satisfaction at being involved with something that is “much larger than myself. I’m a part of a community that works together towards a common goal. It’s nice to be a part of an international team working with people from places and countries who put aside their differences.”

All photos from Janek Uin

Photo from METRO

By Daniel Dunaief

Daniel Dunaief

Welcome to the home office. I have been working from home for years and would like to offer a few tips.

For starters, pets are generally awesome. They can reduce the stress from deadlines and from abrasive calls. Much more often than not, they seem absolutely delighted to see us and to give and receive positive attention.

The wag, wag, wag of a dog’s tail is almost as wonderful as the squeal of a happy toddler when he sees the ice cream on his plate or learns about a trip to the store — ah good times, remember when stores were open? — or to a visit with a favorite relative.

But then there’s the dark side. My big dog offers quiet companionship most of the time. He does, however, have an uncanny knack of barking at what appears to be absolutely nothing outside when I’m on the phone with someone who is coming to the point of a long and deeply moving anecdote.

Nothing takes the professional veneer off an interview with a Nobel Prize winning scientist, the chairman of a department or the head of a medical school faster than the unwelcome sound of a dog barking.

Well, that’s not entirely true. I have exacerbated that dilemma. You see, I thought I hit the mute button on my phone and shouted unpleasant words at my wonderful four-legged companion, only to discover that, in my haste, I missed the button, giving my professional contact an earful of seemingly out-of-my-mind comments. 

So, there are two lessons: Keep your barking dogs far from the phone when possible, and make absolutely sure you push the mute button before breaking character and insisting that your beloved buddy stops barking at the squirrel that tortures him — and you — during important calls.

OK, so the next tip is fairly obvious, but bears repeating. The refrigerator is not calling you. While you’re home, you will undoubtedly have competing impulses that you might not have indulged in at the office with a trip to the kitchen. One of them is to fill the momentary lull between calls, or the period when you might otherwise chat at the watercooler about the latest sports games — ah, remember when we used to watch sports in real time? The kitchen is fine and doesn’t need a visit, especially given the dwindling supply of basic items that might be harder to get the next time you go to the supermarket — ah, remember the good times. OK, you get the idea.

Create signals with the rest of the family, who are home with you or back in the nest to alert them to the most important work-related tasks of your day. If you are on a conference call with people who are signing up for off-site responsibilities for the next few weeks, the last thing you want to do is have someone come to your work space and ask if you’ve seen the blue sock to match the one he’s holding with an exasperated look at your door.

Finally, remember that the kind of things you might say in the context of gossip or jokes don’t always translate through texts and emails. No matter how some emojis might indicate that you’re joking — a winking circular blob, perhaps or a shrugging face — the person on the receiving end of your witticisms might not get it and might not find your brilliance so charming, especially if she’s still upset at the words she screamed at her barking dog earlier in the day.

Photo from YouTube

By Daniel Dunaief

Daniel Dunaief

We take so much of our life for granted. In some ways, it’s natural and necessary. After all, if we got up and stared out our window and marveled at the combination of sun and shade on the branches rocking in the wind, bent down to admire the dew clinging to the grass and breathed deeply of the newly blossoming trees every morning, we might never get our kids to school and ourselves to work.

And yet, all the news about the spread of this new virus and the ensuing reaction to protect the population — from closing schools to avoiding subways to staying away from large crowds — gives us an opportunity to appreciate the things, people and sensory experiences we take for granted.

No one will miss the scent of urine wafting up through the subways during a hot summer day when switching problems make everyone stand four, five and six deep on the platform, waiting for the next overcrowded and overheated subway car to arrive.

Still, we may miss so many other sensory, social and everyday experiences if and when we have to lock ourselves in our homes, waiting for the “all clear” sign.

So, what are some of those experiences? It depends on whom you ask and what time of year the question arises.

I appreciate the joy of people watching. After living in Manhattan for decades, I’ve learned to swing my eyes across the street inconspicuously, while I seemed lost in thought or even pretended to be on an invisible phone. Times Square, with its superabundant tourists speaking uncountable languages, wearing unrecognizable colognes and walking in all manner of shoes, is a great place to start.

But then, the line for the Statue of Liberty and Ellis Island offers a similar variety of people from all over the world. Instead of billboards of half-naked and incredibly tone and muscular bodies advertising Broadway shows and underwear, the backdrop for the people watching at the ferry lines includes the unpredictable waves of the Hudson River, which has its own personality, ranging from near stillness to foaming white caps.

Closer to home and nearer to summer, West Meadow Beach blends the natural with the call of the seagulls across the enormous intertidal zone and the salty, wind-carried scent; and the anthropogenic with the plaintive cry of babies overheated by the hot sun, the sound of music vibrating from sound systems and the sight of happy teenagers taking their first lick of their soft-serve ice cream cones.

I enjoy watching the end of a hard-fought tennis match, when two or four people come to the net and exchange pleasant handshakes and share thoughts about a good match or a good game.

The crowds at sporting events, many of whom we might not choose from a potential lineup of friends, become a part of memorable games and evenings, as we exchange high fives with inebriated strangers, share insights about what we would do if we were the manager of the team, or congratulate the parent of one of the players on our daughter’s team for the improvement in her game.

Despite the fact that I tend to avoid a crowded elevator car, an overstuffed subway or even an escalator with too many tired bodies waiting for a machine to bring them to the top, I will miss the chance to share some of these experiences with the random strangers who might become friends, the fellow sports fans who might offer a game-within-a-game entertainment, or the chance encounter with a long-lost friend whose winsome smile is the same as it was decades ago in an eighth-grade math class.

Maureen O’Leary. Photo courtesy of SBU

By Daniel Dunaief

Like the great white shark that needs to keep swimming to stay alive, scientific databases that provide resources to researchers from all over the world can’t stay still or they risk losing their usefulness and reliability.

The directors of these resources need to find funds that will ensure that the data remains accessible and that users, who range from high school students conducting work for a class to the chairman of research departments at colleges, can benefit from the availability of information.

Maureen O’Leary. Photo from SBU

Maureen O’Leary, a Professor and Graduate Program Director at the Department of Anatomical Sciences at the Renaissance School of Medicine at Stony Brook University, is looking to ensure that Morphobank, a web application and database that allows scientists around the world to share raw data on the structure of various organisms to help determine their evolutionary links, receives funds that sustain its mission.

O’Leary helped start MorphoBank in 2000 to encourage researchers to share data and propel science forward and is currently the director. By making observations of the structures of organisms available in one place online, she hoped to help advance the field of phylogenetics — the relationships among organisms in a family tree — while cutting down on the need to reproduce data from the same fossils at museums or other sites.

Up to this point, O’Leary has found financial support for the effort through grants from the National Science Foundation, the American Museum of Natural History and the National Oceanographic and Atmospheric Administration.

Looking to the future, however, O’Leary wanted to create a financial plan that would ensure ongoing funding for a database that has not only helped researchers explore data, but has also enabled collaborators to share information privately in a non-public area of MorphoBank.

O’Leary has been working with Phoenix Bioinformatics, a nonprofit group based in Fremont, California that has developed funding models for databases. Phoenix started its operations in 2013 after the staff of TAIR, a curated database for plant genome information, lost its grant funding.

The business is in the early stages of helping O’Leary with Morphobank, said Eva Huala, the Executive Director of Phoenix and a founding member of TAIR.

Phoenix has helped construct a financial model that is similar to the way university libraries and scientists pay for subscriptions to journals. The prices vary depending on the database the library subscribes to and the amount of usage of that database from the university. 

Huala said Phoenix is providing software that helps recruit members. The company is also enabling users to see whether their institution is supporting MorphoBank. So far, the Executive Director is “encouraged by the response. We know that this often takes several months or longer for libraries to decide” to lend financial support, she said.

The cost of running MorphoBank is connected to the time people spend curating as well as fixing bugs or managing computer-related challenges. Without software patches and fixes, the databases can run into problems.

Universities often require their researchers to make sure the data they collect is available to the scientific community, Huala explained, adding that MorphoBank can give scientists a way to “demonstrate the impact of their research” by offering download and viewing statistics for their data.

Mike D’Emic, an Assistant Professor in Biology at Adelphi University and a member of the Executive Committee of MorphoBank, has used the database for over seven years.

D’Emic suggested that MorphoBank “saves people from reinventing the wheel in doing science” by providing free, raw data. Scientists don’t have to travel to museums or other sites to gather the same information.

An early career researcher or student might have a small grant to visit three or four museums. These scientists can “supplement that data set with information from MorphoBank that’s multiple times the value of a grant they would have gotten,” D’Emic noted.

Scientists can freely use data from MorphoBank that would have taken tens of thousands of dollars to acquire. This includes photographs of a dinosaur skull from distant countries or CT scans that can be expensive to produce.

D’Emic, who helped convince the Adelphi library to provide financial support for the database, said MorphoBank addresses bug reports quickly, fixing problems with a few days.

Prior to O’Leary’s effort to start MorphoBank, a researcher might need to search through the appendices or the published reports from other scientists in their field to access raw data for tree building, sometimes retyping by hand large spreadsheets of numerical scores.

MorphoBank has been “invaluable and transformative in terms of the way people access and replicate science,” D’Emic said.

Some journals have started urging authors to publish their data online. The Journal of Vertebrate Paleontology strongly recommends uploading dataset, character descriptions and images to an online repository.

“For not too much money, MorphoBank has a huge impact on science,” D’Emic said, who said it was a cost effective boost to evolutionary biology and related fields

Scientists have changed significantly in their approach to sharing information. Around 30 years ago, some researchers wouldn’t always share their raw data. Other scientists would then have to spend thousands of dollars to travel to places like Thailand, Australian and Madagascar.

“People have come around” and are more comfortable exchanging data, sometimes as they produce it, D’Emic said. “MorphoBank has been an integral venue for convincing people you should share.”

O’Leary believes researchers have evolved in the way they think about the information they collect as a part of their studies.“We have reached a social transition where scientists get used to not only writing a paper and walking away, but making sure the data content is in a digitally reusable format,” she said.

O’Leary feels fortunate to have received funding for over two decades for MorphoBank. She plans to remain the director when MorphoBank moves to Phoenix. It’s an “important and dynamic tool” and she feels a “responsibility to allow its continuity.”

 

Stock photo

By Daniel Dunaief

Daniel Dunaief

I just celebrated an incredible birthday, thanks to the thoughtfulness of friends and family who took the time to talk with me and shop for greatly appreciated gifts.

Each year, these birthdays have the potential to be challenging, especially given that mine often comes some time around school midterms. Even though I’m no longer watching the calendar to see how many days I have left before I have to take a big test, I still ride that roller coaster vicariously with my children. This year, however, enormous and difficult tests didn’t hang over us, like the academic sword of Damocles.

For starters, before my birthday celebration kicked in, my sister-in-law and brother-in-law sent me AirPods. I knew I was supposed to open the gift on my birthday, but I’m not exactly the most patient person when it comes to opening presents. Gee, I wonder where my kids get that trait?

Anyway, the reaction from my son was almost as enjoyable as the present itself. When he saw me wearing them, he said, “How did you get those?” as if the question were an accusation. “My friends all have them.”

My daughter did a test run with me, chatting with me on FaceTime while she stared at my ears instead of at my uneven sideburns or the hairy bridge connecting my eyebrows. It’s increasingly rare these days for anything I do, say or wear to be considered “up to date,” so this wonderful gift hit the mark.

I’m enjoying using the AirPods at the gym, where I don’t have to worry about the wire bouncing around when I’m running or after I’ve exercised, when I’m panting as I lean over the water fountain.

The best part, though, is that they allow me to talk with someone while I’m walking my dog and picking up his droppings. I don’t have to worry about the wire coming lose when he suddenly pulls hard on the leash to chase a rabbit or to run away from the sudden noise a desiccated leaf makes when it blows in the wind behind us. Yes, despite his 90-pound body, he finds the unexpected noise from leaves threatening.

While I insisted to my wife that she didn’t need to buy anything for me, she purchased several items of clothing, like shorts and shirts that fit, look good and are incredibly comfortable. She also got this terrific jacket that repels the white dog hair that has rendered the rest of my outerwear ridiculous when interacting with members of the general public.

This birthday we ventured to the Big Easy, where the ubiquitous music still resonates. We took a paddleboat ride and heard about the Mississippi River and the site of the Battle of New Orleans. The oak trees lining the bank are about 250 to 300 years old, which means that the same trees stood in the same spot during the battle. 

My teenage son, who isn’t always the picture of patience with his demanding dad, played with me and allowed me to hug him in public during the weekend. That was better than any gift he could have purchased. My daughter, meanwhile, celebrated vicariously from college. A few of her friends wandered into the screen and wished me the best.

Finally, I connected by phone with college roommates, nephews, brothers and my mom, who was a critical part of that day so many years ago. Birthdays have, at times, made me feel older and displaced. This one, with the meaningful conversations, the laughter with my wife and children and the chats with friends and relatives, as well as the “cool” gifts, made me feel so young.

Members of the team at Brookhaven Lab’s Accelerator Test Facility from left, Mark Palmer, Dejan Trbojevic, Stephen Brooks, George Mahler, Steven Trabocchi, Thomas Roser, and Mikhail Fedurin. Photo from BNL

By Daniel Dunaief

Scientists at Brookhaven National Laboratory and Cornell University have tested and developed a new “green” accelerator. Capturing and reusing the energy from electrons that are decelerating, the newly designed model, called CBETA, will have uses in everything from computer chip manufacture to medicine to missile defense to basic science.

Employing permanent magnets, which require no energy to operate, and superconducting material, these researchers brought to fruition an idea first formulated in 1965 by Maury Tigner, professor emeritus at Cornell University.

“It was talked about for many years,” said Thomas Roser, who just completed his 10th year as chairman of the Collider-Accelerator Department at Brookhaven National Laboratory. “To put everything together in an energy efficient way could have a significant impact for the future.”

Indeed, the new design could lower the energy needs of a future facility like the Electron Ion Collider, which BNL plans to complete in 2030.

“We all have a responsibility to contribute to the well-being” of the planet, including in efforts to reduce the energy consumption of devices used to unlock the mysteries of the universe and produce future technology, said Roser.

Schematic of the Cornell-BNL
ERL Test Accelerator.
Image courtesy of Cornell University

One of the many advantages of the new accelerator design, which was tested in the early morning hours of Dec. 24 at Cornell, is that it captures and reuses the energy in a multi-turn particle accelerator. The idea of the accelerator was to enable beams of different energy to travel through the same magnets on slightly different paths in an oblong structure. 

The design is akin to a relay race on a running track. Each lane has runners that move at their own speeds. When it is time for one of the runners to slow down and leave the track, she shares the energy from her sprint with an intermediary, which drives the next runner forward at a rapid pace, while she decelerates in a nearby loop.

In the case of the accelerator, the intermediary is a superconducting radio frequency cavity.

A key design feature is that multiple beams recirculate in these cavities four times. This cuts down on future construction costs and reduces the size of an accelerator from about a football field to a single experimental hall, according to information from Cornell.

A fresh electron beam allows researchers to get a better quality beam than in the traditional way of operating an accelerator, in a ring that would circulate continuously. 

“The beam is always refreshed, and what gets recirculated is the energy,” Roser said.

The high quality, bright beam creates bright lasers that companies may be able to use to manufacture new chips for computer or phone technology. These accelerators could also make infrared lasers that could melt objects. This type of application could help with defense department efforts to thwart an incoming missile. While BNL is taking steps to work on applications in other areas, the Department of Energy laboratory is not involved in such missile defense applications.

In the medical arena, this kind of accelerator could enable the construction of smaller, simpler and lighter devices for proton therapy to treat cancer. The multi-energy beam transport of CBETA would allow the building of more compact and less expensive gantries that deliver beams to the patient.

Using different energies at the same time, doctors could “treat cancers at different depths inside the body,” Roser said. “That’s an application for this unique transport.” Proton therapy could become cheaper and available in more hospitals with this approach, he asserted.

For Dejan Trbojevic, the principal investigator on the CBETA project and a senior physicist from BNL, the successful test of the concept was a validation of over 20 years of work.

“You can do a lot of simulations assuming realistic errors,” but the actual experiment demonstrating the concept “makes a big difference,” he explained in an email.

The BNL scientist was at Cornell in late December, where he and his colleagues celebrated the results with champagne.

Trbojevic, who had developed the concept of using a single beamline instead of multiple beamlines, hopes to use the new design to create a less expensive design to proton therapy treatment for cancer

“I’m trying to make this cheaper so more hospitals can have it,” Trbojevic said. He has already made contact with companies and a professor in Europe who hopes to use the design concept. He has also requested funding from the Department of Energy.

Beyond the excitement of the recent collaboration with Cornell on the new accelerator design, Roser reflected on his first decade as chairman of the Collider-Accelerator Department.

The BNL department is leading the world in many accelerator technologies and is collaborating closely with CERN, which was founded in Europe seven years after BNL.

Indeed, this year marks numerous celebrations for the department. The Relativistic Heavy Ion Collider, or RHIC, has been operating for 20 years and will become a part of the new Electron Ion Collider. At the same time, the Alternating Gradient Synchrotron, where research for three Nobel Prizes was conducted, marks its 60th year of generating scientific results.

And, to top off the historical trifecta, Ernest Courant, a former BNL Scientist who teamed up with Stanley Livingston and Hartland Snyder to create the strong focusing principle, turns 100 in March. Courant, who worked with Trbojevic on a paper describing the single beamline concept in 1999, helped provide a critical step for modern particle accelerators.

As it did 10 years ago, the department is rolling these three celebrations into one in June.

Courant can’t attend the event because he lives in a retirement home in Ann Arbor, Michigan near his son. BNL will likely show photos and video from Ernest’s birthday at the celebration.

As for the recently completed collaboration with Cornell, Roser believes the work is an important step.

“It’s a new concept and a new type” of accelerator, Roser said. “That doesn’t come around very often. There are cyclotrons and there are linear accelerators. This is a combination of a circular and linear accelerator put together in a new way.”

 

The White House

By Daniel Dunaief

Daniel Dunaief

I want the weakest possible president in 2020.

As a representative democracy, the United States uses a system of governance that relies on checks and balances. Everything about the history of the country makes it clear that a collection of leaders, each with limited power, should reflect the diverse nature of the country, with states that have small populations getting equal representation in the Senate.

Whenever one of the three branches of government oversteps its bounds, the other two have the opportunity to keep that one in check. If, for example, the executive branch, through the president of the United States, takes actions that the legislative or executive branches find objectionable or questionable, Congress or the Supreme Court can hold that president accountable.

So, how do we ensure those checks and balances? Where do we find exactly the right kind of weak president who can do just his or her job without trying to tell the courts what to do or legislate new laws favorable to the officeholder?

Most presidents, including every candidate who seems to be running now, appear to be convinced that he or she will be a strong leader with a vision for the country that takes us to greater heights or that makes us a better nation.

That’s lovely, but no president can do it alone. The government should be a team effort, pulling together people with a drive to contribute to the world through public service and to represent not only personal opinions, but the values, goals and concerns of the entire nation.

That seems almost impossible, given the divided nature of the country as we enter the 2020 election, right? Someone is always winning and someone is always losing.

That doesn’t have to be the case if a president sees and understands the limits of their power.

While this may seem like a direct rebuke of President Donald Trump (R), it is not. If Vermont Sen. Bernie Sanders (I), who seems to be gaining momentum with each passing primary, wins the Democratic nomination and then becomes president, I don’t want him to be powerful, either.

Some of his ideas, like free college and Medicaid for all, seem compelling on the surface, but many Democrats, Republicans and Independents wonder how exactly he’ll pay for all of those ideas. I enjoy reading dystopian fiction, like “1984,” “The Giver,” and “Fahrenheit 451,” to name a few. The conclusions of all of them are that utopia doesn’t work and big government creates even bigger problems, particularly for the individual.

The idea of Medicaid for All may seem appealing because of the frustration so many people feel with their medical insurance, until they imagine the bureaucratic machine known as the federal government making decisions about their medical coverage. Many of us want to make informed choices.

That brings me back to the choice for president. In the next eight months or so, as we prepare for the onslaught of advertisements telling us how and why the other candidate may ruin our lives, We the People can do something about it. If we truly believe a Democrat will win the White House, we can vote for Republicans in Congress. If we believe Trump will continue to share his inspirational Twitter messages wishing everyone well — just a bit of sarcasm here — we should vote Democratic in all the other races.

I don’t want Sanders expanding government and running up a tab that even higher taxes seem incapable of paying, while I also don’t want Trump getting a free pass to follow his impulses where they take him and the rest of the country. For me, the best 2020 choice is a weak and controlled president.

Lingbo Zhang Photo from CSHL

By Daniel Dunaief

In the span of a few months, Lingbo Zhang, a Cold Spring Harbor Laboratory fellow, has made discoveries involving two deadly blood cancers.

In September, Zhang, collaborating with researchers from Memorial Sloan Kettering Cancer Center and the National Institute of Diabetes and Digestive and Kidney Diseases, found a drug target that might eventually lead to a new treatment for myelodysplastic syndrome, which is a common form of blood cancer. The scientists published their work in the journal Science Translational Medicine.

In January, Zhang published work that analyzed the genes that are active in acute myeloid leukemia, which has a five-year survival rate of only 33 percent. 

By studying 230 genes, Zhang found that this form of blood cancer is addicted to higher concentrations of vitamin B6, creating a potential target for future therapy. The CSHL scientist published this work in the journal Cancer Cell.

“We feel humbled that we found a target” for a future AML therapy, Zhang said of his latest discovery. “My lab partners and I think one day we can potentially translate our knowledge into a real therapy. The translational part gives us the energy and encouragement to work hard.”

Indeed, Zhang explained that his work broadly focuses on blood cancer, in which he looks for questions of medical importance. With MDS, he started with the view that many patients with this disease do not respond to the typical treatment using a hormone called erythropoietin, or EPO.

Lingbo Zhang

People with MDS typically have too few red blood cells, which are made in bone marrow. The hormone EPO converts progenitor immature versions of red blood cells into the ones that function in the body. A small percentage of MDS patients, however, respond to EPO. This occurs because people with this disease have a smaller pool of progenitor cells.

Zhang and his colleagues went upstream of those progenitor cells, searching for defective processes earlier in the pathway. They found that a protein receptor, CHRM4, decreases the production of cells that might become red blood cells. 

By inhibiting that receptor, they hoped to restore the red blood cell making process. In mice that have the same blood features as human MDS, this approach worked, restoring the machinery that leads to the production of red blood cells.

With both the MDS and the leukemia studies, these discoveries might lead to a future treatment, but are not necessarily the final step between understanding molecular signals and developing treatments. These findings are transitioning from basic discoveries into the preclinical development of novel therapies, Zhang said.

For MDS, the treatment may be effective with the inhibitor itself, while for AML, it will potentially be effective as part of a therapy in combination with other treatments.

In his work on leukemia, Zhang said the research went through several phases, each of which took several months. For starters, he screened all the potential target genes. Once he performed the initial work, he conducted a validation study, exploring each gene, one by one. Finally, he worked to validate the study.

After all that work, he discovered the role that the gene that makes PDXK, the enzyme that helps cells use vitamin B6, plays in contributing to cancer. Normal, healthy cells use vitamin B6 during metabolism to produce energy and grow. As with most cancers, leukemia involves more cell division than in a healthy cell, which means that the PDXK enzyme is more active.

Scott Lowe, a collaborator on the research and former CSHL fellow who is now the chair of Cancer Biology and Genetics at Memorial Sloan Kettering, expressed surprised at the finding. “While the action of certain vitamins has previously been linked to cancer, the specific links between vitamin B6 identified here were unexpected,” he said in a press release.

A postdoctoral researcher in Zhang’s lab who has been working on the project for two years, Bo Li plans to continue this research and hopes to find a more mechanistic understanding of the discovery.

While this vitamin contributes to cancer, people with leukemia shouldn’t reduce their consumption of B6, which is necessary in healthy cells. If normal and cancer cells both need this vitamin, how could this be a target for drugs?

The difference, Zhang explained, is in the concentration of the enzyme and, as a result, the B6.

PDXK is higher in leukemia. Reducing its activity by inhibiting this activity could affect the disease.

Working with a collaborator at Memorial Sloan Kettering, Zhang is hoping to develop a better chemical compound with the right property to target the activity of this gene and enzyme.

To conduct research into different diseases and pathways, Zhang works with a group of “very talented and hard working people,” in his lab, which includes a few postdoctoral researchers, a doctoral student, a few undergraduates and a technician, bringing his lab’s staff to eight people. “We also have very good collaborators at other institutes and we are able to manage several projects in parallel,” he said.

Zhang said he likes basic and translational science. The basic science brings “beautiful new theories that identify a detail nature created.” He also feels driven to “translate some of these basic discoveries into a potential treatment,” he said. He is working with a foundation and the hospital and receives patient information from them, which encourages him to work hard to seek ways to “benefit them.”

Down the road, he hopes to understand the hierarchical process that leads from stem cells to mature blood cells. By identifying a majority of the players or the regulators, he may be able to understand the different processes involved in the course of numerous diseases.

As for his current work, Zhang is pleased with the potential translational benefit of both discoveries. “I feel very happy that we can identify a target for leukemia and MDS,” he said.

Photo from METRO

By Daniel Dunaief

Daniel Dunaief

She could feel the tension mounting. She had been down this road, or, more specifically, on this runway, numerous times before.

Flying didn’t bother her. She had taken many flights before she met her husband. Since they’d been married, they had also taken trips each year.

That’s when the trouble started. He didn’t blame her, but as someone who shared his feelings and wanted to help him when she could, she often felt at a loss as this moment approached.

She looked at the stranger next to her, eager to encourage a new person to enter the dialogue and distract him from his frustration.

At first, the stranger didn’t engage in conversation, preferring to read his book and to look through the movie offerings on his phone.

The ride around the airport took a while, as the plane stopped a few times to let other flights land.

Unable to break the ice with the man on the other side of her, she turned to her husband and hoped the game they’d developed might help.

“Hey,” she said, “how long do you think it’ll take this time?”

He grumbled something between his gritted teeth.

“Well,” she said, not bothering to ask him to repeat himself when she felt that the words were less relevant than the angry emotion that built up inside of him. “I’m going with eight.”

“Eight?” he spit back at her incredulously. “No way! It’s going to be at least 12.”

When the plane stopped and the Jetway came out to meet it, the man started his stopwatch, holding it up so she could see.

After three minutes, the passenger on her other side, who had heard the abbreviated conversation and could feel the tension rising between them as the man glared, unblinking, at the front of the plane and all the passengers between him and the next step on his trip, decided to break the frustrated silence in their row.

“Are you guys guessing how long it’ll be before you get off the plane?” he asked.

“Yes,” she sighed, grateful for the relief from watching and taking care of her husband.

A flight attendant made an announcement.

“Excuse me, ladies and gentlemen, we’re waiting for a gate attendant to fix the lock on the other side. It should only be a few minutes,” she said.

The man near the window shook his head. The woman shrugged at what she hoped was her new ally.

“Well, we’ll just start now,” she offered, as she set her own stopwatch on her phone and encouraged him to follow the new timing.

“You see,” she said, “he gets angry when people aren’t ready to go after the
plane lands.”

He turned away from the front of the plane long enough to explain himself to the stranger near the aisle.

“They turn off the seatbelt sign and people don’t get their luggage,” he snarled, gesturing with his palm at all the offending passengers between the door to the rest of his travels and the seat that barely contained his irritation. 

“Look at them, sitting there. It’s going to take each of them a while to get off. They have to find their bags, pull them out and get off the plane.”

The stranger offered the weary wife a supportive look. She appreciated the gesture, even as she made sure all her items were ready to go.

“These things are beyond your control,” the stranger offered.

“That’s true, but it still bothers him,” she sighed as she held her bags tightly in her hand.